Ampio pharmaceuticals regains compliance with nyse american continued listing standards

Englewood, colo. , dec. 27, 2022 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe) (the "company") today announced that it has received notification from the nyse american llc ("nyse american") stating that the company has regained compliance with the nyse american's continued listing standards.
AMPE Ratings Summary
AMPE Quant Ranking